Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Lyon, a critical place for performing Virology research.

Gerlier D, Gruffat H, Mahieux R.

Virologie (Montrouge). 2019 Mar 1;23(2):43-44. doi: 10.1684/vir.2019.0766. French. No abstract available.

2.

Regulation of measles virus gene expression by P protein coiled-coil properties.

Bloyet LM, Schramm A, Lazert C, Raynal B, Hologne M, Walker O, Longhi S, Gerlier D.

Sci Adv. 2019 May 8;5(5):eaaw3702. doi: 10.1126/sciadv.aaw3702. eCollection 2019 May.

3.

Type I Interferon Receptor Signaling Drives Selective Permissiveness of Astrocytes and Microglia to Measles Virus during Brain Infection.

Welsch JC, Charvet B, Dussurgey S, Allatif O, Aurine N, Horvat B, Gerlier D, Mathieu C.

J Virol. 2019 Jun 14;93(13). pii: e00618-19. doi: 10.1128/JVI.00618-19. Print 2019 Jul 1.

PMID:
31019048
4.

An ultraweak interaction in the intrinsically disordered replication machinery is essential for measles virus function.

Milles S, Jensen MR, Lazert C, Guseva S, Ivashchenko S, Communie G, Maurin D, Gerlier D, Ruigrok RWH, Blackledge M.

Sci Adv. 2018 Aug 22;4(8):eaat7778. doi: 10.1126/sciadv.aat7778. eCollection 2018 Aug.

5.

[How is transcription reinitiation governed in measles virus?]

Bloyet LM, Roche P, Gerlier D, Longhi S.

Med Sci (Paris). 2017 Oct;33(10):843-845. doi: 10.1051/medsci/20173310010. Epub 2017 Oct 10. French. No abstract available.

6.

Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.

Tartour K, Nguyen XN, Appourchaux R, Assil S, Barateau V, Bloyet LM, Burlaud Gaillard J, Confort MP, Escudero-Perez B, Gruffat H, Hong SS, Moroso M, Reynard O, Reynard S, Decembre E, Ftaich N, Rossi A, Wu N, Arnaud F, Baize S, Dreux M, Gerlier D, Paranhos-Baccala G, Volchkov V, Roingeard P, Cimarelli A.

PLoS Pathog. 2017 Sep 28;13(9):e1006610. doi: 10.1371/journal.ppat.1006610. eCollection 2017 Sep.

7.

How order and disorder within paramyxoviral nucleoproteins and phosphoproteins orchestrate the molecular interplay of transcription and replication.

Longhi S, Bloyet LM, Gianni S, Gerlier D.

Cell Mol Life Sci. 2017 Sep;74(17):3091-3118. doi: 10.1007/s00018-017-2556-3. Epub 2017 Jun 9. Review.

PMID:
28600653
8.

Assessing mycoplasma contamination of cell cultures by qPCR using a set of universal primer pairs targeting a 1.5 kb fragment of 16S rRNA genes.

Jean A, Tardy F, Allatif O, Grosjean I, Blanquier B, Gerlier D.

PLoS One. 2017 Feb 22;12(2):e0172358. doi: 10.1371/journal.pone.0172358. eCollection 2017.

9.

Modulation of Re-initiation of Measles Virus Transcription at Intergenic Regions by PXD to NTAIL Binding Strength.

Bloyet LM, Brunel J, Dosnon M, Hamon V, Erales J, Gruet A, Lazert C, Bignon C, Roche P, Longhi S, Gerlier D.

PLoS Pathog. 2016 Dec 9;12(12):e1006058. doi: 10.1371/journal.ppat.1006058. eCollection 2016 Dec.

10.

Structural Analysis of dsRNA Binding to Anti-viral Pattern Recognition Receptors LGP2 and MDA5.

Uchikawa E, Lethier M, Malet H, Brunel J, Gerlier D, Cusack S.

Mol Cell. 2016 May 19;62(4):586-602. doi: 10.1016/j.molcel.2016.04.021.

11.

HSP90 Chaperoning in Addition to Phosphoprotein Required for Folding but Not for Supporting Enzymatic Activities of Measles and Nipah Virus L Polymerases.

Bloyet LM, Welsch J, Enchery F, Mathieu C, de Breyne S, Horvat B, Grigorov B, Gerlier D.

J Virol. 2016 Jul 11;90(15):6642-6656. doi: 10.1128/JVI.00602-16. Print 2016 Aug 1.

12.

Fuzzy regions in an intrinsically disordered protein impair protein-protein interactions.

Gruet A, Dosnon M, Blocquel D, Brunel J, Gerlier D, Das RK, Bonetti D, Gianni S, Fuxreiter M, Longhi S, Bignon C.

FEBS J. 2016 Feb;283(4):576-94. doi: 10.1111/febs.13631. Epub 2016 Jan 12.

13.

Measles Virus: Identification in the M Protein Primary Sequence of a Potential Molecular Marker for Subacute Sclerosing Panencephalitis.

Kweder H, Ainouze M, Brunel J, Gerlier D, Manet E, Buckland R.

Adv Virol. 2015;2015:769837. doi: 10.1155/2015/769837. Epub 2015 Oct 26.

14.

Kinetic discrimination of self/non-self RNA by the ATPase activity of RIG-I and MDA5.

Louber J, Brunel J, Uchikawa E, Cusack S, Gerlier D.

BMC Biol. 2015 Jul 28;13:54. doi: 10.1186/s12915-015-0166-9.

15.

Heparan sulfate-dependent enhancement of henipavirus infection.

Mathieu C, Dhondt KP, Châlons M, Mély S, Raoul H, Negre D, Cosset FL, Gerlier D, Vivès RR, Horvat B.

MBio. 2015 Mar 10;6(2):e02427. doi: 10.1128/mBio.02427-14.

16.

RIG-I self-oligomerization is either dispensable or very transient for signal transduction.

Louber J, Kowalinski E, Bloyet LM, Brunel J, Cusack S, Gerlier D.

PLoS One. 2014 Sep 26;9(9):e108770. doi: 10.1371/journal.pone.0108770. eCollection 2014.

17.

Sequence of events in measles virus replication: role of phosphoprotein-nucleocapsid interactions.

Brunel J, Chopy D, Dosnon M, Bloyet LM, Devaux P, Urzua E, Cattaneo R, Longhi S, Gerlier D.

J Virol. 2014 Sep;88(18):10851-63. doi: 10.1128/JVI.00664-14. Epub 2014 Jul 9.

18.

Mutation of the TYTLE motif in the cytoplasmic tail of the sendai virus fusion protein deeply affects viral assembly and particle production.

Essaidi-Laziosi M, Shevtsova A, Gerlier D, Roux L.

PLoS One. 2013 Dec 10;8(12):e78074. doi: 10.1371/journal.pone.0078074. eCollection 2013.

19.

Dissecting partner recognition by an intrinsically disordered protein using descriptive random mutagenesis.

Gruet A, Dosnon M, Vassena A, Lombard V, Gerlier D, Bignon C, Longhi S.

J Mol Biol. 2013 Sep 23;425(18):3495-509. doi: 10.1016/j.jmb.2013.06.025. Epub 2013 Jun 25.

PMID:
23811056
20.

Emerging zoonotic viruses: new lessons on receptor and entry mechanisms.

Gerlier D.

Curr Opin Virol. 2011 Jul;1(1):27-34. doi: 10.1016/j.coviro.2011.05.014. Epub 2011 Jun 12. Review.

PMID:
22440564
21.

[RIG-I: a viral RNA detector molecular switch].

Kowalinski E, Louber J, Gerlier D, Cusack S.

Med Sci (Paris). 2012 Feb;28(2):136-8. doi: 10.1051/medsci/2012282006. Epub 2012 Feb 27. French. No abstract available.

22.

Plasticity in structural and functional interactions between the phosphoprotein and nucleoprotein of measles virus.

Shu Y, Habchi J, Costanzo S, Padilla A, Brunel J, Gerlier D, Oglesbee M, Longhi S.

J Biol Chem. 2012 Apr 6;287(15):11951-67. doi: 10.1074/jbc.M111.333088. Epub 2012 Feb 8.

23.

Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA.

Kowalinski E, Lunardi T, McCarthy AA, Louber J, Brunel J, Grigorov B, Gerlier D, Cusack S.

Cell. 2011 Oct 14;147(2):423-35. doi: 10.1016/j.cell.2011.09.039.

24.

Virus-driven conditional expression of an interferon antagonist as a tool to circumvent host restriction.

Gerlier D.

Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17239-40. doi: 10.1073/pnas.1114431108. Epub 2011 Oct 10. No abstract available.

25.

Rapid titration of measles and other viruses: optimization with determination of replication cycle length.

Grigorov B, Rabilloud J, Lawrence P, Gerlier D.

PLoS One. 2011;6(9):e24135. doi: 10.1371/journal.pone.0024135. Epub 2011 Sep 7.

26.

Interplay between innate immunity and negative-strand RNA viruses: towards a rational model.

Gerlier D, Lyles DS.

Microbiol Mol Biol Rev. 2011 Sep;75(3):468-90, second page of table of contents. doi: 10.1128/MMBR.00007-11. Review.

27.

Nipah virus uses leukocytes for efficient dissemination within a host.

Mathieu C, Pohl C, Szecsi J, Trajkovic-Bodennec S, Devergnas S, Raoul H, Cosset FL, Gerlier D, Wild TF, Horvat B.

J Virol. 2011 Aug;85(15):7863-71. doi: 10.1128/JVI.00549-11. Epub 2011 May 18.

28.

Cellular receptors, differentiation and endocytosis requirements are key factors for type I IFN response by human epithelial, conventional and plasmacytoid dendritic infected cells by measles virus.

Duhen T, Herschke F, Azocar O, Druelle J, Plumet S, Delprat C, Schicklin S, Wild TF, Rabourdin-Combe C, Gerlier D, Valentin H.

Virus Res. 2010 Sep;152(1-2):115-25. doi: 10.1016/j.virusres.2010.06.013. Epub 2010 Jun 23.

PMID:
20600391
29.

The interaction between the measles virus nucleoprotein and the Interferon Regulator Factor 3 relies on a specific cellular environment.

Colombo M, Bourhis JM, Chamontin C, Soriano C, Villet S, Costanzo S, Couturier M, Belle V, Fournel A, Darbon H, Gerlier D, Longhi S.

Virol J. 2009 May 15;6:59. doi: 10.1186/1743-422X-6-59.

30.

Measles virus interaction with host cells and impact on innate immunity.

Gerlier D, Valentin H.

Curr Top Microbiol Immunol. 2009;329:163-91. Review.

PMID:
19198566
31.

Human C3 deficiency associated with impairments in dendritic cell differentiation, memory B cells, and regulatory T cells.

Ghannam A, Pernollet M, Fauquert JL, Monnier N, Ponard D, Villiers MB, Péguet-Navarro J, Tridon A, Lunardi J, Gerlier D, Drouet C.

J Immunol. 2008 Oct 1;181(7):5158-66.

32.

Refined study of the interaction between HIV-1 p6 late domain and ALIX.

Lazert C, Chazal N, Briant L, Gerlier D, Cortay JC.

Retrovirology. 2008 May 13;5:39. doi: 10.1186/1742-4690-5-39.

33.

High-density rafts preferentially host the complement activator measles virus F glycoprotein but not the regulators of complement activation.

Ghannam A, Hammache D, Matias C, Louwagie M, Garin J, Gerlier D.

Mol Immunol. 2008 Jun;45(11):3036-44. doi: 10.1016/j.molimm.2008.03.013. Epub 2008 May 2.

PMID:
18455798
34.

Structure of the measles virus H glycoprotein sheds light on an efficient vaccine.

Ruigrok RW, Gerlier D.

Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20639-40. Epub 2007 Dec 17. No abstract available.

35.

Cell-cell fusion induced by measles virus amplifies the type I interferon response.

Herschke F, Plumet S, Duhen T, Azocar O, Druelle J, Laine D, Wild TF, Rabourdin-Combe C, Gerlier D, Valentin H.

J Virol. 2007 Dec;81(23):12859-71. Epub 2007 Sep 26.

36.

Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response.

Plumet S, Herschke F, Bourhis JM, Valentin H, Longhi S, Gerlier D.

PLoS One. 2007 Mar 14;2(3):e279.

37.

Viral hijacking of cellular ubiquitination pathways as an anti-innate immunity strategy.

Chen M, Gerlier D.

Viral Immunol. 2006 Summer;19(3):349-62. Review.

38.

Inhibition of ubiquitination and stabilization of human ubiquitin E3 ligase PIRH2 by measles virus phosphoprotein.

Chen M, Cortay JC, Logan IR, Sapountzi V, Robson CN, Gerlier D.

J Virol. 2005 Sep;79(18):11824-36.

39.
40.
41.

Dynamics of viral RNA synthesis during measles virus infection.

Plumet S, Duprex WP, Gerlier D.

J Virol. 2005 Jun;79(11):6900-8.

42.

Cell surface activation of the alternative complement pathway by the fusion protein of measles virus.

Devaux P, Christiansen D, Plumet S, Gerlier D.

J Gen Virol. 2004 Jun;85(Pt 6):1665-73.

PMID:
15166451
43.

Measles virus protein interactions in yeast: new findings and caveats.

Chen M, Cortay JC, Gerlier D.

Virus Res. 2003 Dec;98(2):123-9.

PMID:
14659559
44.

Ligand binding determines whether CD46 is internalized by clathrin-coated pits or macropinocytosis.

Crimeen-Irwin B, Ellis S, Christiansen D, Ludford-Menting MJ, Milland J, Lanteri M, Loveland BE, Gerlier D, Russell SM.

J Biol Chem. 2003 Nov 21;278(47):46927-37. Epub 2003 Sep 3.

45.

A physical and functional link between cholesterol and tetraspanins.

Charrin S, Manié S, Thiele C, Billard M, Gerlier D, Boucheix C, Rubinstein E.

Eur J Immunol. 2003 Sep;33(9):2479-89.

46.

Virus entry, assembly, budding, and membrane rafts.

Chazal N, Gerlier D.

Microbiol Mol Biol Rev. 2003 Jun;67(2):226-37, table of contents. Review.

47.

Multiple levels of interactions within the tetraspanin web.

Charrin S, Manié S, Billard M, Ashman L, Gerlier D, Boucheix C, Rubinstein E.

Biochem Biophys Res Commun. 2003 Apr 25;304(1):107-12.

PMID:
12705892
48.
49.

Strength of envelope protein interaction modulates cytopathicity of measles virus.

Plemper RK, Hammond AL, Gerlier D, Fielding AK, Cattaneo R.

J Virol. 2002 May;76(10):5051-61.

50.

A CD46CD[55-46] chimeric receptor, eight short consensus repeats long, acts as an inhibitor of both CD46 (MCP)- and CD150 (SLAM)-mediated cell-cell fusion induced by CD46-using measles virus.

Christiansen D, De Sousa ER, Loveland B, Kyriakou P, Lanteri M, Wild FT, Gerlier D.

J Gen Virol. 2002 May;83(Pt 5):1147-55.

PMID:
11961270

Supplemental Content

Loading ...
Support Center